Cannabinoids in Neurology - Position paper from Scientific Departments from Brazilian Academy of Neurology.
Sonia Maria Dozzi BruckiTarso AdoniCarlos Maurício Oliveira de AlmeidaDaniel Ciampi de AndradeRenato AnghinahLuciana Mendonça BarbosaRodrigo BazanAlzira Alves de Siqueira CarvalhoWilliam CarvalhoPaulo Pereira ChristoMarcus Vinicius Della ColettaAdriana Bastos ConfortoYlmar Correa NetoEliasz EngelhardtMarcondes Cavalcante de França JuniorClélia Maria Ribeiro FrancoFelipe von Glehn SilvaHélio Rodrigues GomesCaroline Gomes de Barros HoulyAlexandre Ottoni KaupFernando KowacsAline Mizuta Kozoroski KanashiroVictor Gonçalves LopesDébora Palma MaiaMaria Luíza Giraldes de ManrezaAlberto Rolim Muro MartinezSandra Cristina Gonçalves MartinezSaulo Nardy NaderLuciana de Oliveira NevesIvan Hideyo OkamotoRogério Adas Ayres de OliveiraFabiano de Melo PeixotoCristiana Borges PereiraRoberta Arb SabaLetícia Pereira de Brito SampaioLucas Porcello SchillingMarcus Tulius Teixeira da SilvaEmanuelle Roberta da Silva AquinoJerusa SmidCristiane Nascimento SoaresManoel Alves Sobreira-NetoNise Alessandra De Carvalho SousaLeonardo Cruz de SouzaHélio Augusto Guizoni TeiveVera Cristina TerraMatheus ValeVitor Mendes Grise VieiraEdmar ZanoteliGilmar Fernandes do PradoPublished in: Arquivos de neuro-psiquiatria (2021)
Cannabinoids comprehend endocannabinoids, phytocannabinoids, and synthetic cannabinoids, with actions both in the central and peripherical nervous systems. A considerable amount of publications have been made in recent years, although cannabis has been known for over a thousand years. Scientific Departments from the Brazilian Academy of Neurology described evidence for medical use in their areas. Literature is constantly changing, and possible new evidence can emerge in the next days or months. Prescription of these substances must be discussed with patients and their families, with knowledge about adverse events and their efficacy.